Shanghai Rendu Biotechnology Co., Ltd.SSE: 688193

Report for Q3 2024

Oct 30, 2024 · Issued by Shanghai Rendu Biotechnology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 30, 2024

On 6ix: 6ix.com/news/report-for-q3-2024-309

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Rendu Biotechnology Co., Ltd. on 6ix

Earlier from Shanghai Rendu Biotechnology

Announcement on Implementation of Semi-annual Dividend Distribution in 2024Oct 22, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024Sep 20, 2024
Announcement on Attending 2024 Online Collective Reception Day for Investors of Listed Companies in Shanghai Jurisdiction and Semi-annual Report Performance BriefingSep 6, 2024
Announcement on Semi-annual Profit Distribution Plan 2024Aug 30, 2024
Announcement on Implementation Result of Repurchasing Shares and Share ChangesAug 20, 2024

Later from Shanghai Rendu Biotechnology

Announcement on Attending Collective Q3 Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2024Nov 6, 2024
Announcement on Release of Pledge of Shares Held by Shareholders with Over 5% SharesDec 19, 2024
Announcement on Resolutions of the 8th Meeting of the 2nd Board of SupervisorsJan 18, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 28, 2025
Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public OfferingMar 21, 2025

All Shanghai Rendu Biotechnology news releases

Follow Shanghai Rendu Biotechnology into a list and get an email when it puts out news.

Follow Shanghai Rendu Biotechnology